Related Experiment Video
Updated: May 22, 2026

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Exhaled breath condensate purines correlate with lung function in infants and preschoolers
Kavita Patel1, Stephanie D Davis, Robin Johnson
1Department of Pediatric Pulmonology, University of North Carolina, Chapel Hill, North Carolina, USA.
Insights
Exhaled breath condensate (EBC) purines, like adenosine (Ado) and adenosine monophosphate (AMP), can be safely measured in young children. The EBC AMP/Ado ratio shows potential as a non-invasive marker for monitoring airway inflammation in pediatric respiratory diseases.
Area of Science:
- Pediatric Pulmonology
- Biomarker Discovery
- Respiratory Medicine
Background:
- Airway inflammation is an early characteristic of pediatric chronic respiratory diseases.
- Current assessment methods are invasive and carry significant risks for young children.
- Exhaled breath condensate (EBC) offers a potential less invasive alternative for monitoring airway inflammation.
Purpose of the Study:
- To establish the feasibility and utility of measuring EBC purine biomarkers in preschool children.
- To assess the safety and efficacy of EBC collection during infant pulmonary function tests (iPFTs).
- To explore the correlation between EBC biomarkers and infant lung function measures.
Main Methods:
- EBC was collected from children under 3 years old with lung diseases during iPFTs.
- Adenosine (Ado) and adenosine monophosphate (AMP) concentrations were measured using mass spectrometry.
- The AMP to Ado ratio (AMP/Ado) was analyzed in relation to lung function parameters.
Main Results:
- EBC was successfully collected from 15 out of 17 preschool children without significant changes in vital signs.
- EBC Ado and AMP were measurable in most samples, including those from children with cystic fibrosis (CF).
- The EBC AMP/Ado ratio showed significant correlations with measures of infant lung function (FEV0.5 and RV/TLC).
Conclusions:
- EBC collection and analysis are safe and feasible in preschool children using standard equipment.
- The EBC AMP/Ado ratio may serve as a valuable, less invasive tool for assessing airway inflammation in this population.
- This method holds promise for improved monitoring of pediatric respiratory conditions like CF.
Rationale:
Although airway inflammation begins early in life in children with chronic respiratory diseases, current methods to assess this inflammation are invasive and entail significant risk. Measurement of exhaled breath condensate (EBC) purines and other biomarkers offers a less invasive method to assess airway inflammation; however, the feasibility and utility of EBC biomarkers in young children has not been established.
Methods:
EBC was collected from children <3 years old with cystic fibrosis or other lung diseases during clinically indicated infant pulmonary function tests (iPFTs). EBC concentrations of the purine biomarkers adenosine (Ado), adenosine monophosphate (AMP), and the dilution marker urea were measured using mass spectrometry.
Results:
EBC was successfully collected (average volume 330 ± 170 µl) from preschool children (age 2.3 ± 0.8 years) in 15 of 17 iPFTs. No significant changes in oxygen saturation (96.9 ± 1.6 start, 96.8 ± 1.7 end, P = 0.389) or respiratory rate (35.2 ± 7.5 start, 34.6 ± 7.9 end, P = 0.443) were observed during collection. Ado and AMP were successfully measured in 13/15 samples [8 cystic fibrosis (CF)]. EBC AMP to Ado ratio (AMP/Ado) negatively correlated with forced expiratory volume at 0.5 sec (FEV(0.5) , r = -0.71, P < 0.01) and positively with the ratio of residual volume to total lung capacity (RV/TLC, r = 0.66, P = 0.015). These correlations remained statistically significant in the subset with CF.
Conclusions:
EBC can be safely collected and analyzed in preschool children using commercially available equipment. The EBC AMP/Ado ratio correlates with measures of infant lung function and may be a less invasive means of monitoring airway inflammation in this population.
Related Concept Videos
Pulmonary Cycle: Exhalation
Breathing
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...

